Alzheimer's disease progression linked to microglia fat metabolism, potential new treatment target identified in recent study ...

The mice used in this study lacked amyloid plaques on blood vessels, so the researchers could not evaluate what happens when blood vessel plaques are removed. They are working with a different mouse ...

Clumps or plaques of the protein beta-amyloid in the brain are a hallmark of a type of dementia called Alzheimer’s disease. When beta-amyloid plaques form, they disrupt communication between ...

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...

The researchers discovered that STING, an immune molecule meant to protect the brain, may actually be making things worse as ...

Whole blood exchange reduces the formation of amyloid beta plaques in mouse models of Alzheimer's disease. The corresponding study was published in Nature. A buildup of amyloid proteins in the brain ...

Mice that overexpress the human mutant amyloid precursor protein (hAPP) show learning deficits, but the apparent lack of a relationship between these deficits and the progressive β-amyloid plaque ...

New research shows that low-intensity repetitive transcranial magnetic stimulation (rTMS) can restore key synaptic structures ...

"Protein tangles and plaques have been the focus of Alzheimer's treatments for decades," says Walton. "What we're showing for the first time is that immune cells can be trained to recognize not just ...

The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.

Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The ...